Logo
x

Search category

Subscribe Now

All Posts by Date

Confo Therapeutics Entered into a Global License Agreement with Eli Lilly for CFTX-1554

Confo Therapeutics Entered into a Global License Agreement with Eli Lilly for CFTX-1554

  • March 2, 2023
Zack Usilton, Chief Development Officer at Senta Partners Shares Insights from their Partnership with Reston ENT to Expand its Network of ENT Practices

Zack Usilton, Chief Development Officer at Senta Partners Shares Insights from their Partnership with Reston ENT to Expand its Net...

  • March 2, 2023
Should You Be Considering Dental Cosmetic Surgeries

Should You Be Considering Dental Cosmetic Surgeries

  • March 2, 2023
Biogen Launches Byooviz (biosimilar, ranibizumab) for the Treatment of Retinal Disorders in Canada

Biogen Launches Byooviz (biosimilar, ranibizumab) for the Treatment of Retinal Disorders in Canada

  • March 2, 2023
Sanofi and Sobi Report P-III Study (XTEND-Kids) Results of Altuviiio for the Treatment of Hemophilia A in Children Aged <12 Years

Sanofi and Sobi Report P-III Study (XTEND-Kids) Results of Altuviiio for the Treatment of Hemophilia A in Children Aged <12 Years

  • March 2, 2023
ImmunoGen Signs a Multi-Target License and Option Agreement with Vertex to Develop Novel Targeted Conditioning Agents

ImmunoGen Signs a Multi-Target License and Option Agreement with Vertex to Develop Novel Targeted Conditioning Agents

  • March 2, 2023
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.